Literature DB >> 530565

Diabetic macular edema and argon laser photocoagulation: a prospective randomized study.

G W Blankenship.   

Abstract

Loss of vision from diabetic retinopathy can result from complications of neovascular proliferation, or frequently, from macular edema secondary to background diabetic retinopathy. Although the benefits of photocoagulation for proliferative diabetic retinopathy have been clarified by the National Eye Institute's collaborative diabetic retinopathy study, those for background diabetic retinopathy with macular edema remain unclear. Several articles have described the visual benefits and reduction of edema following photocoagulation of eyes with background diabetic retinopathy and macular edema, but only Patz's study was prospectively designed utilizing a random assignment of laser treatment for one eye with the other eye remaining untreated. This article reports the two-year results of a similar prospective study in which one eye in each of 39 patients with symmetrical macular edema secondary to background diabetic retinopathy was randomly selected to receive argon laser photocoagulation, while the fellow eye remained untreated.

Entities:  

Mesh:

Year:  1979        PMID: 530565     DOI: 10.1016/s0161-6420(79)35534-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Sanjay Sharma; Jeff Bakal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-31       Impact factor: 3.117

2.  The effect on the macular function of laser photocoagulation for diabetic macular edema.

Authors:  E Midena; T Segato; G Bottin; S Piermarocchi; I Fregona
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 3.  Diabetic retinopathy (treatment).

Authors:  Quresh Amir Mohamed; Adam Ross; Colin Jonathan Chu
Journal:  BMJ Clin Evid       Date:  2011-05-25

4.  Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy.

Authors:  T W Gardner
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.

Authors:  T E Rohan; C D Frost; N J Wald
Journal:  BMJ       Date:  1989-11-11

6.  Subthreshold micropulse diode laser treatment in diabetic macular oedema.

Authors:  M L Laursen; F Moeller; B Sander; A K Sjoelie
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

Review 7.  Diabetic retinopathy.

Authors:  Efstratios Mendrinos; Alexandros N Stangos; Constantin J Pournaras
Journal:  BMJ Clin Evid       Date:  2007-11-23

8.  Spontaneous evolution and photocoagulation of diabetic cystoid macular edema.

Authors:  P Massin-Korobelnik; A Gaudric; G Coscas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-05       Impact factor: 3.117

9.  Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema.

Authors:  Remzi Avci; Berkant Kaderli; Berrin Avci; Saban Simsek; Mehmet Baykara; Zeynep Kahveci; Oner Gelisken; Ahmet Ali Yucel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-22       Impact factor: 3.117

10.  Progression of diabetic retinopathy after cataract extraction.

Authors:  A Pollack; S Dotan; M Oliver
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.